-
CN
亿懿兴华
Shikimic acid
current location: Home · Product · Cases ·
Development
2019.6
Project approval for the key intermediate shikimic acid of the biosynthesis of influenza specific drug oseltamivir phosphate
2020.8
Complete the technical renovation of the pilot production workshop for oxalic acid
2021.8
Successful pilot scale of the first generation biosynthesis of shikimic acid
2021.11
Initiate and lead the standard development of the purity standard sample for mangiferic acid
2022.3
Build a production line for oxalic acid and achieve large-scale production of oxalic acid
2022.9
Mangoxalic acid, as a new type of veterinary medicine, has entered the national major special "unveiling and commanding" project
Product standards

Product description: Shikimic acid crystalline powder produced by fermentation of genetically engineered Escherichia coli bacteria with glucose as substrate


Physical properties:

(1) Appearance: This product is a white uniform powder.

(2) Solubility: Easily soluble in water, with a solubility of 18g/100ml, but insoluble in chloroform, benzene, and petroleum ether.


Physical, chemical, and microbiological indicators:

(1) Content: ≥ 98%

(2) Moisture content: ≤ 1.0%

(3) Total ash content: ≤ 1.0%

(4) Specific rotation: -180 °

(5) Total colony count: ≤ 1000

(6) Total number of molds and yeast: ≤ 100

(7) Coliform group: cannot be detected

(8) Salmonella: cannot be detected


Pollutant indicators:

Lead (Pb): ≤ 2.0

Arsenic (As): ≤ 2.0

Cadmium (Cd): ≤ 1.0

Mercury (Hg): ≤ 0.1

Storage: Dry and sealed at 2-8 ℃ in a dark place, with an expiration date of 24 months.